NCT01982604

Comparison of 30 Units of TI (Technosphere® Insulin) Prepared With Insulin From Two Different Suppliers

A Phase 1, Open-label, Randomized, Crossover Clinical Trial to Evaluate PK/PD of 30 U TI Inhalation Powders Prepared With Insulin From Two Different Suppliers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 38 (actual)
• Sponsor: Mannkind Corporation · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

A Phase 1, open-label randomized crossover trial in Healthy Volunteers to evaluate the PK/PD of TI (Technosphere® Insulin) prepared with insulin from two different suppliers.

Conditions

• Healthy Volunteers

Interventions

Type	Name	Description
DRUG	TI-Inhalation Powder A	Inhaled Insulin
DRUG	TI-Inhalation Powder B	Inhaled Insulin

Timeline

• Start date: 2013-11-01
• Primary completion: 2014-02-01
• Completion: 2014-08-01
• First posted: 2013-11-13
• Last updated: 2014-10-02

Locations

1 site across 1 country: United States